14th week of 2013 patent applcation highlights part 32 |
Patent application number | Title | Published |
20130084291 | COMPOSITIONS AND METHODS FOR INCREASING SERUM HALF-LIFE - Provided herein are glycovariant Fc fusion proteins having increased serum half lives. Also provided are methods for increasing the serum half life of an Fc fusion protein by introducing one or more non-endogenous glycosylation sites. | 2013-04-04 |
20130084292 | Antagonists for the Prevention of Treatment of Inflammatory Bowel Disease, and More Particularly of Crohn's Disease - An antagonist of the interaction between the Gp96 receptor and | 2013-04-04 |
20130084293 | HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION - Methods of treating a food allergy, allergic reactions, hypersensitivity, inflammatory responses, inflammation are provided. In one method, histamine releasing factor (HRF)/translationally controlled tumor protein (TCTP) is contacted with a compound that inhibits or reduces binding of HRF/TCTP to an immunoglobulin in order to treat the food allergy, allergic reaction, hypersensitivity, inflammatory response, or inflammation. Methods of reducing or decreasing the probability, severity, frequency, duration or preventing a subject from having an acute or chronic food allergy, allergic reaction, hypersensitivity, an inflammatory response or inflammation, are also provided. In one method, histamine releasing factor (HRF)/translationally controlled tumor protein (TCTP) is contacted with a compound that inhibits or reduces binding of HRF/TCTP to an immunoglobulin in order to reduce or decrease the probability, severity, frequency, duration or prevent a subject from having an acute or chronic food allergy, allergic reaction, hypersensitivity, an inflammatory response or inflammation. | 2013-04-04 |
20130084294 | ANTI-CD19 ANTIBODIES AND USES IN B CELL DISORDERS - The invention relates to immunotherapeutic compositions and methods for the treatment of B cell diseases and disorders in human subjects, such as, but not limited to, B cell malignancies and autoimmune diseases and disorders, using therapeutic antibodies that bind to the human CD19 antigen and that preferably mediate human ADCC. The present invention relates to pharmaceutical compositions comprising human or humanized anti-CD19 antibodies of the IgG1 or IgG3 human isotype. The present invention relates to pharmaceutical compositions comprising human or humanized anti-CD19 antibodies of the IgG2 or IgG4 human isotype that preferably mediate human ADCC. The present invention also relates to pharmaceutical compositions comprising chimerized anti-CD19 antibodies of the IgG1, IgG2, IgG3, or IgG4 isotype that mediate human ADCC. In preferred embodiments, the present invention relates to pharmaceutical compositions comprising monoclonal human, humanized, or chimeric anti-CD19 antibodies. | 2013-04-04 |
20130084295 | ANTI-INTERFERON-ALPHA ANTIBODIES - The present invention relates generally to the generation and characterization of neutralizing anti-IFN-α monoclonal antibodies with broad reactivity against various IFN-α subtypes. The invention further relates to the use of such anti-IFN-α antibodies in the diagnosis and treatment of disorders associated with increased expression of IFN-α, in particular, autoimmune disorders such as insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE). | 2013-04-04 |
20130084296 | MODULATION OF SRPX2-MEDIATED ANGIOGENESIS - The present invention relates to nucleic acids and antibodies against SRPX2 and SRPX2 protein function in angiogenesis. Angiogenesis-related conditions, such as cancer or wound healing, can be treated by the composition comprising the SRPX2 antagonists or agonists, respectively. | 2013-04-04 |
20130084297 | Anti-ErbB3 Antibodies and Uses Thereof - The present invention provides antibodies that bind to ErbB3 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human ErbB3. In certain embodiments, the antibodies of the present invention block the interaction of ErbB3 with an ErbB3 ligand such as neuregulin 1. The antibodies of the invention are useful for the treatment of various cancers. | 2013-04-04 |
20130084298 | NOVEL ANTI-CLATHRIN HEAVY CHAIN MONOCLONAL ANTIBODY FOR INHIBITION OF TUMOR ANGIOGENESIS AND GROWTH AND APPLICATION THEREOF - A purified monoclonal antibody, or an. antigen-binding portion thereof, which specifically binds to human clathrin heavy chain (CHC) is disclosed. The antibody, or antigen-binding portion, thereof, exhibits at least one, two, three, four, five, six, seven, or all eight of the following properties: (a) specifically binds to pancreatic adenocarcinoma cells; (b) binding to the cell surface and cytosol of cancer cells and tumor blood vessels; (c) internalized by CHC-expressing cells; (d) inhibiting tumor growth, invasion ability, migration, and angiogenesis; (e) inducing apoptosis in cancer cells and human umbilical vein endothelial cells; (f) inhibiting tumor growth and tumor blood vessels in pancreatic cancer in vivo; (g) suppressing epidermal growth factor, transferrin, and VEGF internalizations by cancer cells; and (h) suppressing hypoxia-inducible factor-1α expression and vascular endothelial growth factor secretion. Methods for inhibiting tumor cell growth and/or angiogenesis, and detecting cancer in a subject is also disclosed. | 2013-04-04 |
20130084299 | METHODS - The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided. | 2013-04-04 |
20130084300 | DIAGNOSIS AND PREVENTION OF CANCER CELL INVASION - The present invention relates to diagnostic and therapeutic methods in the field of malignant disorders. More particularly, the invention provides methods of determining the invasivity of malignant disorders and methods for reducing the invasivity of malignant disorders including the prevention or treatment of cancer cell invasion. | 2013-04-04 |
20130084301 | Cluster of Neutralizing Antibodies to Hepatitis C Virus - Compositions and methods are provided relating to human anti-HCV E2 monoclonal antibodies. The antibodies of the invention bind to a conserved region of HCV E2 protein, and neutralize HCV influenza virus across multiple HCV genotypes. Embodiments of the invention include isolated antibodies and derivatives and fragments thereof, pharmaceutical formulations comprising one or more of the human anti-HCV monoclonal antibodies; and cell lines that produce these monoclonal antibodies. | 2013-04-04 |
20130084302 | Methods of binding TNF-alpha using Anti-TNF-alpha antibody fragment-polymer conjugates - Described are conjugates formed by an antibody fragment covalently attached to a nonproteinaceous polymer, wherein the apparent size of the conjugate is at least about 500 kD. The conjugates exhibit substantially improved half-life, mean residence time, and/or clearance rate in circulation as compared to the underivatized parental antibody fragment. Also described are conjugates directed against human vascular endothelial growth factor (VEGF), human p185 receptor-like tyrosine kinase (HER2), human CD20, human CD18, human CD11a, human IgE, human apoptosis receptor-2 (Apo-2), human tumor necrosis factor-α (TNF-α), human tissue factor (TF), human α | 2013-04-04 |
20130084303 | PEPTIDES SHARED AMONG LETHAL CANCERS AND THERAPEUTIC COMPOSITIONS COMPRISING SAID PEPTIDES - The present invention provides cancer peptides related to rapid replication and shared among different histological cancer types. The peptides are provided in compositions for interfering with replication in cancer, in preventive and therapeutic vaccines, and in diagnostic applications. The compositions for interfering with replication in cancer are useful for preventing and treating different histological types of cancer including ectodermic, endodermic, and mesodermic cancers as well as cancers arising in association with HIV. | 2013-04-04 |
20130084304 | VACCINE AND METHODS TO REDUCE CAMPYLOBACTER INFECTION - Vaccine vectors and methods for enhancing resistance to | 2013-04-04 |
20130084305 | COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT - It is an object of the present invention to provide a cosmetic or external skin preparation that has an improved feel in use, e.g., excellent stretching on the skin surface, excellent permeation into the skin, and no stickiness, or crinkles. A cosmetic or an external skin preparation, and a medical instrument, comprising at least one lipid peptide-based gelator that contains a low-molecular lipid peptide of Formula (1): | 2013-04-04 |
20130084306 | VACCINES COMPRISING CHOLESTEROL AND CPG AS SOLE ADJUVANT-CARRIER MOLECULES - Described are vaccines having one or more antigens cholesterol and CpG. Aspects of the invention relate to the use of the vaccines of the invention for the treatment and/or prevention of human and animal disorders. | 2013-04-04 |
20130084307 | VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT - Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glucopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous form. Chemically defined, synthetic GLA offers a consistent vaccine component from lot to lot without the fluctuations in contaminants or activity that compromise natural-product adjuvants. Also provided are vaccines and pharmaceutical compositions that include GLA and one or more of an antigen, a Toll-like receptor (TLR) agonist, a co-adjuvant and a carrier such as a pharmaceutical carrier. | 2013-04-04 |
20130084308 | ANTI-ARTHROPOD VECTOR VACCINES, METHODS OF SELECTING AND USES THEREOF - The present disclosure provides methods of selecting and uses of anti-arthropod vector vaccines to prevent Leishmaniasis. The present disclosure also provides compositions for vaccines to prevent Leishmaniasis. | 2013-04-04 |
20130084309 | PROCESS FOR THE PREPARATION OF O/W EMULSION - The present invention provides a process for the production of an oil in water emulsion comprising the steps of: a) dissolving a surfactant in a volume of water or aqueous solution to produce a surfactant solution; and b) diluting the surfactant solution in a volume of water or aqueous solution greater than the volume of the surfactant solution to produce an aqueous phase. | 2013-04-04 |
20130084310 | COMPOSITIONS AND METHODS FOR PLATELET ENRICHED FIBRIN CONSTRUCTS - Compositions and methods are provided for tissue constructs that promote wound healing. The composition comprises a dimensionally stable fibrin construct for local administration to a wound site or region. In one embodiment, the fibrin construct is a wound healing composition, including components that promote wound healing, such as platelets, growth factors, white blood cells and fibrin clots. In another embodiment, the tissue treatment composition includes (i) aggregated fibrin, (ii) blood cells, and (iii) optionally, growth factors and/or other proteins. | 2013-04-04 |
20130084311 | Lingual Vestibular Dosage-form and Delivery System for Transmucosal Administration of Pharmaceutical Agents - A pharmaceutical delivery system enabling the oral transmucosal administration of active pharmaceutical agents in a situation where rapid transmucosal administration is preferred to prevent the delay and decomposition of the agents in passing through the intestinal tract. The delivery system comprises a supportive substrate with bilateral lingual vestibular flanges connected at the anterior midline to form a ‘U’ like shape for fitting in the potential space of the bilateral lingual vestibules, and further comprising a handle or tab for holding the device in the mouth of a patient with altered consciousness to prevent aspiration or premature swallowing. The pharmaceutical dosage-form is formulated and shaped to contact the mucosal tissues and may include mucoadhesive compounds, retentive compounds, and/or additional payload enhancers, such as permeation enhancers and flavor enhancers. | 2013-04-04 |
20130084312 | NANOPARTICLES FOR DELIVERY OF BIOACTIVE AGENTS - Biocompatible polymeric nanoparticles for delivery of bioactive agents, and methods for preparing the particles, are described. Polyoxalate nanoparticles of the subject technology show desired particle sizes suitable for use in drug delivery and a substantially uniform or narrow particle size distribution. The polyoxalate nanoparticles can contain water-soluble, poorly water-soluble, or water-insoluble drugs. The nanoparticles are nontoxic and are generally safe for use in humans. After being administered into the body, the nanoparticles with a high content of a bioactive agent entrapped therein can safely deliver the agent to target sites and stably release the drug at a controlled rate. | 2013-04-04 |
20130084313 | SUPPLEMENT FOR OSTOMY PATIENTS - The present application describes a supplement containing an enteric coated alpha-D-galactosidse and the use thereof to treat an ostomy patient. | 2013-04-04 |
20130084314 | Expandable Placental Membrane and Methods of Making and Storing Same - A placental membrane including a plurality of slits for increasing the membrane's capacity to expand. The slits are provided through the membrane and provided in sufficient numbers across the surfaces of the membrane to produce a mesh-like pattern in the membrane. The mesh-like pattern enables the placental membrane to be stretched and therefore increased in length and width. For ease of handling and storage, the expandable placental membrane is removably adhered to a backing, rolled into a cylinder and placed within a capped vial containing a solution of amniotic fluid cells for improving the effectiveness of the membrane. | 2013-04-04 |
20130084315 | CONTROLLING RESORPTION OF BIORESORBABLE MEDICAL IMPLANT MATERIAL - The resorption of a medical implant can be controlled with the use of particles embedded in a resorbable bulk material forming the implant or portion thereof. The implant can be removed from a body of a mammal by natural biological mechanisms after use. The resorption of the implant can involve swelling and/or hydrolyzing of the particles within the implant upon contact with a body fluid such that porosity and flow of fluid within the bulk material of the implant is increased. Resorption of the implant may also involve the use of particles with magnetic properties embedded within the implant such that an applied magnetic field causes the particles to vibrate within the bulk material thereby increasing the porosity and thus the flow of fluid, hence facilitating resorption of the implant. The resorption rate of the implant can be controlled by modulating swelling, hydrolysis, or movement of the embedded particles. | 2013-04-04 |
20130084316 | ARRAY WITH FINE PROTRUSIONS | 2013-04-04 |
20130084317 | Low Calorie Composite Sweetener As Sugar Alternative And Methods For Producing The Same - The invention provides a process for producing a low calorie composite sweetener as a sugar alternative. The invention further provides a low calorie composite sweetener that can be used in many products. The low calorie composite sweetener is useful as non-caloric sweeteners in edible and chewable compositions such as any beverages, confectionaries, bakeries, cookies, chewing gums, and alike. | 2013-04-04 |
20130084318 | MICROSPHERES AND PHOTOPROTECTIVE PERSONAL CARE COMPOSITION COMPRISING SAME - The invention relates to photoprotective cosmetic compositions comprising microspheres and a process to prepare them. In particular, the invention is especially effective in protecting the skin against visible solar radiation while ensuring a highly acceptable even skin tone and appearance. The present inventors have developed a microsphere with hollow interior and shell of a material having a specific optical property and specific thickness and coated with another material having a different specific optical property, a combination of which gives the microsphere surprising benefits both in terms of protection from the harmful sun rays while giving a pleasing skin appearance when these microspheres are incorporated in topical compositions. | 2013-04-04 |
20130084319 | BROAD-SPECTRUM ANTIMICROBIAL COMPOSITIONS BASED ON COMBINATIONS OF TAUROLIDINE AND PROTAMINE AND MEDICAL DEVICES CONTAINING SUCH COMPOSITIONS - Novel antimicrobial compositions and coatings are disclosed. The antimicrobial compositions consist of mixtures of taurolidine and protamine, including protamine salts. The antimicrobial compositions are particularly useful in coatings for implantable medical devices. The antimicrobial compositions are effective against a broad spectrum of microbes. | 2013-04-04 |
20130084320 | TISSUE FUSION METHOD USING COLLAGENASE FOR REPAIR OF SOFT TISSUE - The present invention provides a method of using locally administered collagenase as a non-invasive means of enhancing cell release from the cartilage or fibrocartilage tissues adjacent to a disease or injury site. The subsequent migration of cells from these tissues into the lesion or wound, followed by deposition of the appropriate extracellular matrix, results in closure of the lesion or fusion of a tissue gap. | 2013-04-04 |
20130084321 | OLEOPHILIC ANTIMICROBIAL COMPOSITION - The present invention relates to an oleophilic antimicrobial composition comprising silica nanotubes containing silver nanoparticles. The composition is added to an oil-based composition, such as an oil-based paint, a ceramic composition or a fiber coating compositions, immediately before the use of the oil-based composition, such that the contact time of the silver nanoparticles with the organic solvent contained in the oil-based composition is shortened to inhibit the oxidation of the silver nanoparticles. In addition, the composition has improved antimicrobial effects due to the excellent dispersibility of the silver nanoparticles, because the silver nanoparticles do not agglomerate in any solvent due to the silica nanotube structures, unlike spherical silica structures. | 2013-04-04 |
20130084322 | DRUG-IMPREGNATED BIODEGRADABLE STENT AND METHODS OF MAKING THE SAME - The present invention relates to a drug-impregnated implantable medical device such as stent manufactured from polymers, and more particularly, biodegradable polymers including biodegradable polyesters. The invented medical devices include at least one therapeutic agent impregnated in at least one biodegradable polymer wherein at least a portion of the therapeutic agent in this polymer is crystalline. The device and methods to impregnated one or more therapeutic agents, where each therapeutics agent may be chosen from the following categories: immunosuppressant agents, anti-neoplastic agents and anti-inflammatory agents were disclosed. Other embodiments include methods of fabricating drug-impregnated implantable medical devices. | 2013-04-04 |
20130084323 | FENESTRATED HEMOSTATIC PATCH - A hemostat comprises a non-porous patch made of a bio-resorbable tissue compatible material, said patch having a tissue-facing surface and a top surface; an optional hemostatic agent that is disposed on said tissue-facing surface or optionally dispersed throughout said patch or optionally as a separate carrier layer, and at least one aperture or slit that penetrates said patch at least partially from said tissue-facing surface to said top surface. | 2013-04-04 |
20130084324 | ADHESION PREVENTION FABRIC - The present invention is directed to an adhesion prevention fabric having a first absorbable oxidized regenerated cellulose nonwoven fabric and a second absorbable oxidized regenerated cellulose woven or knitted fabric. Further disclosed is an adhesion prevention fabric that is useful for adhesion prevention in the presence of blood. | 2013-04-04 |
20130084325 | MANUFACTURING METHOD OF PATCH PREPARATION - The invention provides a method of manufacturing a patch preparation comprising (a) pouring a composition for forming an adhesive layer into a container having a concave part with a shape corresponding to a patch preparation to be manufactured, wherein the composition contains a drug, an adhesive polymer, and an organic solvent; (b) removing the organic solvent from the composition through drying to form a drug-containing adhesive layer in the concave part; and (c) laminating a support on the drug-containing adhesive layer to provide the patch preparation comprising a support and the drug-containing adhesive layer formed on one surface of the support. | 2013-04-04 |
20130084326 | LIPOSOMES FOR THE ORAL DELIVERY OF THERAPEUTIC AGENTS - The invention relates to liposomes having membranes composed of amphipathic molecules and long chain lipids in ratios that are proportionately higher in amphipathic molecules. Such ratios enhance the enzymatic breakdown of the inventive liposomes thereby improving the bioavailabity of encapsulated substances for oral delivery. Compositions of liposomes and methods of their use and manufacture are within the scope of the invention. | 2013-04-04 |
20130084327 | POLYNUCLEOTIDE ENCODING A TRIM-CYP POLYPEPTIDE, COMPOSITIONS THEREOF, AND METHODS OF USING SAME - The invention provides an isolated nucleic acid encoding a TRIM-cyclophilin A fusion sequence encoding a TRIMcyp fusion protein which is active as an anti-viral agent, and in particular an anti-HIV-1 agent. The invention provides for a nucleic acid encoding a polypeptide having both TRIM activity and cyclophilin activity. The invention provides for an isolated polynucleotide encoding a TRIM-cyclophilin fusion protein, or variants thereof retaining the TRIM and cyclophilin activities. The invention provides for compositions thereof, antibodies that specifically bind thereto, and vectors and host cells comprising the nucleic acid or polypeptide. In addition, the invention provides for methods for treating or preventing viral infection, or reducing viral load in a subject comprising administering the nucleic acid, polypeptide, vector, or composition to the subject in an amount effective to treat or prevent the viral infection. | 2013-04-04 |
20130084328 | METHYLATED CODING AND NON-CODING RNA GENES AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR HUMAN MELANOMA - Provided herein are methods for the diagnosis and treatment of human melanoma and prediction of early disease genesis to metastasis by assessing CpG island methylation or expression level of epigenetically regulated differentially expressed coding or non-coding genes. Methods of treatment of human melanoma by modifying or regulating the same pathways are also provided. | 2013-04-04 |
20130084329 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASES - The present invention relates to a composition for external application for improving a skin disease (e.g. psoriasis). The composition contains adenosylcobalamin (coenzyme B12), optionally in admixture with other cobalamins. The composition can be present in the form of liposomal preparations, which are made of a phospholipid and cholesterol. | 2013-04-04 |
20130084330 | COMPOSITION FOR THE TREATMENT OF ARTHRITIS CONTAINING A DIBENZO-P-DIOXIN DERIVATIVE AS THE ACTIVE INGREDIENT - Disclosed is a composition for treating arthritis containing a dibenzo-p-dioxin derivative as an active ingredient. This dibenzo-p-dioxin derivative is very effective in inhibiting NF-kB and AP-1 activity, alleviates the symptoms of degenerative arthritis and rheumatoid arthritis without irritating the skin or causing side effects, and can continue to exhibit improvement effects for a considerable period of time after discontinuation of treatment. Additionally, when the dibenzo-p-dioxin derivative is contained in liposomes, the composition of the invention exhibits much greater effects on treating arthritis by absorption through skin, and thus is useful for the treatment of degenerative arthritis and rheumatoid arthritis. | 2013-04-04 |
20130084331 | Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors - A bifunctional shRNA-based composition and methods for knocking down the expression of the PDX-1 oncogene in target cells is described herein. The invention also provides methods to deliver the shRNA-containing expression vectors to target tissues overexpressing the PDX-1 oncogene. | 2013-04-04 |
20130084332 | TASTE MASKED PHARMACEUTICAL COMPOSITION - This application relates to taste masked multi-layered particles an inert core, one or more coating layer(s) comprising a pharmaceutically active ingredient and a binder, an intermediate coating layer (seal coating) free from a low molecular weight water-soluble ionic compound and comprising a water-soluble pharmaceutical film-forming compound selected from (i) HPMC and PEG or (ii) PVP, and an outer coating layer (final or taste masking coating) free from a low molecular weight water-soluble ionic compound and comprising (i) a poly(meth)acrylate or (ii) a mixture comprising 60-90% (w/w) EC and 10-40% (w/w) HPMC, wherein the pharmaceutically active ingredient is water-soluble and comprises either at least one basic group and/or a bitter taste. Further disclosed are methods for the production of such particles and pharmaceutical compositions comprising them. | 2013-04-04 |
20130084333 | ABUSE RESISTANT ORAL DOSAGE FORMS - Aspects of the present invention are directed to abuse resistant oral dosage forms comprising a compressed microtablet that is coated with a water-retardant polymer. Additional aspects of the present invention are directed to an oral dosage form comprising an opioid agonist and at least one compressed microtablet coated with a water retardant polymer. The compressed microtablet may comprise an opioid antagonist. | 2013-04-04 |
20130084334 | PHARMACEUTICAL COMPOSITIONS HIGHLY DOSED WITH BIOTIN - The invention relates to novel pharmaceutical compositions highly dosed with biotin, as well as to the use thereof in treating visual impairments which are related, in particular, to optic atrophy. | 2013-04-04 |
20130084335 | IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION - The present invention relates to a pharmaceutical composition containing ivabradine or a pharmaceutically acceptable salt thereof. The invention further relates to a method for the preparation of such a composition. | 2013-04-04 |
20130084336 | ENHANCED NITRIC OXIDE DELIVERY AND USES THEREOF - Methods and compositions are disclosed that enhance delivery of nitric oxide (NO) by combining nitric oxide releasing nanoparticles (NO-np) with exogenous glutathione (GSH), as well as therapeutic uses of the methods and compositions. | 2013-04-04 |
20130084337 | PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME - The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage. | 2013-04-04 |
20130084338 | Method For Producing Solid Pigment-Containing Film Coating Compositions In The Form Of Granules Based On Enteric Film Formers For Pharmaceutical Dosage Forms - Method for producing pigment-containing granules for pharmaceutical applications based on film-forming enteric polymers, wherein the production of the granules takes place by a spraying process in which the enteric polymeric film formers are introduced as initial charge in a fluidized bed, and an aqueous pigment suspension, which comprises a plasticizer that is solid at 20° C., is sprayed onto the fluidized bed. | 2013-04-04 |
20130084339 | COMPOSITION COMPRISING ALUMINUM SILICATES AND SILVER NANOPARTICLES AS BACTERICIDES - The present invention relates to a composition comprising a nanocomposite or nanostructured powder which comprises an aluminium silicate and, distributed on the surface thereof, silver nanoparticles with sizes of less than 50 nm, to its use as a bactericide and to a process for obtaining said composition. | 2013-04-04 |
20130084340 | Compositions and Methods of Making Sustained Release Liquid Formulations - The present invention includes compositions and methods for the controlled release of active agents in a shelf-stable liquid formulation by blending one or more controlled release microbeads comprising one or more active agents, preparing a dense, thixotropic solution having a density that is at, or about, the density of the one or more microbeads comprising a thixotropic agent, water and one or more preservatives under conditions that reduce bubble formation and mixing the microbeads and the thixotropic solutions in a mixer that lacks scraping paddles. | 2013-04-04 |
20130084341 | Compositions and Methods to Promote Implantation and Engrafment of Stem Cells - Tissue repair in-vivo depends on acute inflammation, but in many clinical situations the other major components of healing such as blood supply, anabolic hormones, growth factors, and stem cells are lacking. This invention includes compositions consisting of an agent which induces an inflammatory healing response combined with an autologous platelet lysate at a specific concentration which may have demonstrated in-vitro abilities to expand autologous tissue repair cells. | 2013-04-04 |
20130084342 | PHARMACEUTICAL COMPOSITION - A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. | 2013-04-04 |
20130084343 | METHODS OF DETECTING SEPSIS - Methods of sepsis in a sample from a patient are provided. Methods of detecting changes in expression of one or more RNAs associated with sepsis are also provided. Compositions and kits are also provided. | 2013-04-04 |
20130084344 | COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION - The present invention relates to compositions, kits and methods for the administration of various vitamin, mineral and nutrient compositions, and in a specific embodiment, the compositions, kits and methods may utilize or include twelve carbon chain fatty acids and/or twelve carbon chain acylglycerols, vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega 3 fatty acids and one or more pharmaceutically acceptable carriers. | 2013-04-04 |
20130084345 | INDIBULIN THERAPY - The invention provides combination therapy, wherein one or more other therapeutic agents are administered with indibulin or a pharmaceutically acceptable salt thereof and the combination is synergistic. Another aspect of the invention relates to the treatment of cancer with indibulin as a single agent. Another aspect of the invention relates to dosing regimen for administration of oral dosage forms of indibulin. | 2013-04-04 |
20130084346 | INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS - The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved. | 2013-04-04 |
20130084347 | Natural insect repellent compositions - An alcohol-free insect repellent composition includes: (a) from about 30 to about 60 weight % of lemongrass oil; (b) from about 15 to about 40 weight % of essential oil of lemon eucalyptus; (c) from about 10 to about 30 weight % of rose geranium oil; and (d) from about 2 to about 20 weight % of litsea cubeba oil; the balance of the insect repellent composition to 100 weight % being water; wherein the insect repellent composition is free of non-naturally occurring ingredients. This simplified abstract is not intended to limit, and should not be interpreted as limiting, the scope of the claims. | 2013-04-04 |
20130084348 | COMPOSITIONS COMPRISING NON-ACIDIC BOSWELLIA OIL FRACTION AS A BIO-ENHANCER FOR ENHANCING BIOAVAILABILITY OF BIOLOGICAL AGENTS - The invention relates to a non-acidic | 2013-04-04 |
20130084349 | EXTRUSION DIE HOUSING AND INSERT - A die for a pellet mill is presented, where the die includes a permanent die housing, and a removable cutting insert that is received by the die housing. The interior region of the die housing is adjacent to the exterior region of the die. The die insert contains multiple extrusion holes, and the die housing has corresponding extension holes. The insert may be keyed into the housing to ensure the extrusion holes of the insert align with extension holes in the housing. | 2013-04-04 |
20130084350 | Venturi effect technology on a food product molding machine - An apparatus and method for creating a venturi effect in a food product molding machine. The venturi effect accelerates food product in order to cause the product to be stretched aligning the fibers of the product. | 2013-04-04 |
20130084351 | STAMPING APPARATUS FOR STAMPING SHADING FILM - A stamping apparatus for stamping a shading film includes a stamping head, at least one locking member and a sleeving ring. The sleeving ring defines an axial sleeving hole and includes a stamping portion formed on a distal end thereof and surrounding the axial sleeving hole. The sleeving ring is detachably sleeved on and locked to the stamping head via the at least one locking member. The stamping portion matches with the stamping head for cooperatively stamping the shading film. | 2013-04-04 |
20130084352 | MOLD HAVING RELEASE LAYER FOR IMPRINTING, METHOD FOR PRODUCING MOLD HAVING RELEASE LAYER FOR IMPRINTING, AND METHOD FOR PRODUCING COPY MOLD - Provided is a mold having a release layer, in which the release layer is disposed in the mold which transfers a specific uneven pattern onto a molding material to be patterned by means of an imprinting method, wherein the main chain of the molecular chains of a compound contained in the release layer contains a fluorocarbons, the molecular chains of the compound have at least two adsorption functional groups that are adsorbed or bonded to the mold, the bonding energy in the adsorption functional groups that becomes the source of adsorption or bonding of the adsorption functional groups to the mold is greater than the bonding energy between one adsorption functional group and another adsorption functional group in the molecular chains of the compound, and the surface free energy of the release layer is optimized by means of heating. | 2013-04-04 |
20130084353 | STAMP FOR MOLDING LENSES - There is provided a stamp for molding lenses, including: a first stamp including a plurality of first lens molding parts; and a second stamp including a plurality of second lens molding parts corresponding to the plurality of first lens molding parts, wherein the first lens molding parts have different sizes so as to mold at least two types of lens. | 2013-04-04 |
20130084354 | OVENS FOR PREFORMS - Ovens for preforms in plastic material, applicable in particular but not exclusively to blowing machines and stretch blowing machines, are provided. | 2013-04-04 |
20130084355 | Melt Channel Geometries for an Injection Molding System - An injection molding system is disclosed that utilizes a melt channel wherein at least a portion of the melt channel has a noncircular cross-section for balancing shear in a melt stream of moldable material that flows therethrough. The noncircular cross-section of the melt channel portion may be, for e.g., capsule-shaped, extended egg-shaped, oval, teardrop-shaped, or peanut-shaped. A flow splitter is also disclosed that is positioned offset from a central axis of an upstream melt channel to protrude between inlets of respective downstream melt channels, where the upstream melt channel splits into the downstream melt channels, to thereby create a narrower inlet into one of the downstream melt channels and a wider inlet into the other of the downstream melt channels. | 2013-04-04 |
20130084356 | CLAY INTERLACED YEAST COMPOSITIONS AND METHODS OF UTILIZING THE SAME - The present invention relates to compositions comprising yeast cells and/or yeast cell components and methods for producing and utilizing the same. In particular, the invention provides novel yeast comprising altered cell wall structure (e.g., clay and/or clay component(s) integrated (e.g., interlaced) into cell wall(s) and/or cell wall(s) comprising altered glucan:mannan ratio), methods of producing the same, compositions comprising and/or derived from the same, and methods of using the same (e.g., to sequester and/or adsorb bacteria and toxins). Compositions and methods of the invention find use in a variety of applications including dietary (e.g., admixing with feedstuffs or otherwise feeding to animals), therapeutic, prophylactic (e.g. admixing with bedding sources and/or other materials that come into contact with animals, usage during food and beverage processing and manufacture, and usage during filtration of liquids) as well as research applications. | 2013-04-04 |
20130084357 | Composition for Promoting Bioabsorption of Flavonoid, Food/Beverage for Promoting Bioabsorption of Flavonoid Using the Composition, and Method for Production of the Food/Beverage - Disclosed is a flavonoid bioabsorption-promoting composition or food/beverage which can improve the bioabsorption of quercetin or other flavonoids having antioxidant effect and is effective for the prevention of various diseases. It is found that ingestion of apple pectin can improve the bioabsorption of quercetin and other flavonoids and shows higher physiological activity. Based on this finding, a flavonoid bioabsorption-promoting composition or food/beverage can be provided, which contains apple pectin as an active ingredient and therefore can improve the bioabsorbability of a flavonoid and show a flavonoid bioabsorption-promoting activity. By using apple pectin or a food additive containing apple pectin, it becomes possible to provide a food or beverage which contains quercetin or other flavonoids, which are popularly ingested and which are classified in to a category of a processed food including a soft drink, supplement, seasoning, confectionery, and a prepared meal. | 2013-04-04 |
20130084358 | Method To Reduce Biogenic Amine Content in Food - This invention relates to a method of reducing biogenic amine content in a beverage by contacting the beverage and/or beverage intermediate with an enzyme having transglutaminase activity. | 2013-04-04 |
20130084359 | FERMENTED BEVERAGE AND METHOD OF PRODUCTION - The present disclosure includes a fermented beverage. The fermented beverage includes water, barley, wheat, hops, yeast, goji berries and jujube fruit. The method of the present disclosure is directed to a method of producing a fermented beverage. | 2013-04-04 |
20130084360 | NOVELTY SNACKS AND METHOD OF MANUFACTURE OF SAME - A method for manufacturing a snack food with from a non-cohesive homogeneous blend of ingredients using an ultrasonic horn and an anvil to form an agglomerated, cohesive and portable snack without the use of additives, including but not limited to preservatives, plasticizers, binders and fluidizers. | 2013-04-04 |
20130084361 | VEGAN SIMULATED EGG COMPOSITIONS AND METHODS - The present invention relates to compositions and methods for preparation of vegan simulated egg yolks, simulated egg whites, and simulated whole eggs consisting of the vegan simulated egg yolk and egg white compositions, for consumption. The compositions simulate sensorily an animal-derived egg, such as a chicken egg, and may have the same protein and vitamin content. | 2013-04-04 |
20130084362 | METHODS AND COMPOSITIONS FOR IMPROVING THE NUTRITIONAL CONTENT OF MUSHROOMS AND FUNGI - An improved filamentous fungi is disclosed that has an enhanced nutritional profile by utilizing pulsed ultraviolet irradiation. According to the invention, the vitamin D component of mushrooms and other filamentous fungi may be drastically increased with no deleterious affects on appearance with the use of pulsed UV radiation. Mushrooms so treated had up to 1800% DV in one serving of fresh mushrooms. | 2013-04-04 |
20130084363 | PORTION CAPSULE FOR PRODUCING A BEVERAGE - A portion capsule for producing a beverage includes a cavity for a beverage raw material, wherein an opening can be made in the portion capsule for producing the beverage. | 2013-04-04 |
20130084364 | Dairy-Based Foods Having High Levels Of Lactose - A dairy-based food component is provided that includes high levels of lactose in moisture, but still retains a smooth and creamy consistency. The compositions and methods provide for higher levels of lactose in moisture phase than previously found possible and still retain low crystal sizes in a finished product to maintain a smooth and creamy texture. | 2013-04-04 |
20130084365 | EDIBLE TOY - A toy article comprising at least one connection element and being made of a material configured to be rigid when in a dry state and flexible after being wetted, and being edible. | 2013-04-04 |
20130084366 | ARTIFICIAL SHELL FOR COOKING - An artificial shell for cooking includes, a top portion, having a fill opening therethrough, a bottom portion, and a fill opening cover. The top portion is removably attachable to the bottom portion and the top portion and bottom portion together define an inner storage chamber. Furthermore, the fill opening cover completely covers the fill opening. | 2013-04-04 |
20130084367 | MULTI-FUNCTION CONDIMENT CONTAINER - A container for condiments includes a container portion having generally planar bottom, a generally parallel flange, and defining a cavity having a discharge spout adjacent the parallel flange. The container further includes a generally planar cover portion fashioned from a material more flexible that the material of the container portion and secured to the flange by an adhesive. The container preferably includes a weakened region transversely aligned with the spout but not having fluid communication therewith. Moreover, the container preferably includes a peel initiating structure aligned with the spout but spaced therefrom effective to reduce the peeling force required to separate the cover portion from the container portion. | 2013-04-04 |
20130084368 | Metering the Disposition of a Food Product into Cavities Forming a Pellet - A process for metering the disposition of a food product into cavities forming a pellet. The cavities are defined in one of a conveyor as individual cavities and in a tray moved by the conveyor. Each cavity defines a specific volume. The process includes supplying a quantity of food product in a supply chamber which includes a plurality of nozzles aligned above the conveyor. The nozzles are aligned with a predetermined portion of the cavities. A predefined supply of food product is dispensed and metered through each nozzle. The food product is dispenses through the nozzles into the cavities without exceeding the specific volume of the cavity. The food product is frozen into an individual quick frozen pellet starting immediately upon disposition in one of the cavities. The step of metering the predefined amount of food product includes metering a predetermined weight of the food product. | 2013-04-04 |
20130084369 | METHOD FOR CONTROLLING A COOKING PROCESS - In a method for controlling a cooking process of a cooking item contained in a cooking container, the sound of the cooking process is detected by means of at least one acoustic sensor and the course of the sound is directly analyzed for determining of a temperature and in particular the boiling point of the cooking item. | 2013-04-04 |
20130084370 | VISCOSITY-CONTROLLED PROCESSING OF LIQUID FOOD - The present invention relates to a method of controlling, by open-loop or closed-loop control, the processing of a liquid food product, comprising the steps of providing data that are obtained from mathematical modeling of the dependency of the viscosity of liquid food products on the shear rate, measuring the viscosity of the liquid food product to be processed at a predetermined shear rate at a measuring point, and controlling, by open-loop or closed-loop control, the processing of the liquid food product at a working device downstream of the measuring point in response to the viscosity measured at the measuring point and on the basis of the provided data. | 2013-04-04 |
20130084371 | Silver and Germanium Electrodes In Ohmic And PEF Heating - A method of heating a liquid comprises heating the liquid with an ohmic or PEF heater comprising at least one silver or silver alloy electrode or germanium or germanium alloy electrode. Silver or germanium ions are leached from the at least one silver electrode in an amount to provide the antimicrobial effect in the liquid. The liquid may contain particulates. The electrodes provide product stability and longer shelf life. | 2013-04-04 |
20130084372 | Whole-Muscle Jerky Slice Production Using Bulk Form Processing - An automated method for producing whole-muscle jerky slices using bulk form processing, and further provides jerky slices of novel composition resulting from the practice of such a method. The automated method forms a chilled bulk form of meat from multiple pieces of meat having intact muscle fiber and slices the chilled bulk form. This bulk form processing reduces raw material and labor costs relative to conventional methods for producing whole-muscle jerky slices that require large slabs of meat as input to the production process and substantial human intervention in the production process (e.g., hand-loading and placement). The jerky slices comprise integrated portions of dried meat having intact muscle fiber sourced from multiple animals and cut from a single bulk form. | 2013-04-04 |
20130084373 | Metering The Disposition Of A Food Product Into Cavities Forming A Pellet - A process for metering the disposition of a food product into cavities forming a pellet. The cavities are defined in a conveyor as individual cavities. Each cavity defines a specific volume. The process includes supplying a quantity of food product in a supply chamber which includes a plurality of nozzles aligned above the conveyor. The nozzles are aligned with a predetermined portion of the cavities. A predefined supply of food product is dispensed and metered through each nozzle. The food product is dispensed through the nozzles into the cavities without exceeding the specific volume of the cavity. The food product is frozen into an individual quick frozen pellet starting immediately upon disposition in one of the cavities. The step of metering the predefined amount of food product includes metering a predetermined weight of the food product. | 2013-04-04 |
20130084374 | BAG, PARTICULARLY RE-BAKING BAG, MADE OF GLASSINE PAPER OR CELLULOSE PAPER WITH A FLUORINE COATING - A bag containing foods, particularly foods to be re-heated or cooked and/or bakery products which are pre-baked and/or need to be re-baked, with an essentially closed bottom end and an opposing opening end, comprises a front wall and a rear wall that are attached to each other, at least in one or more sections, directly or through side walls, in the region of their side edges and bottom edges. The front wall and/or the rear wall and optionally also at least one side wall, preferably all side walls, comprise or are made of glassine paper and/or cellulose paper with a single- or double-sided fluorine coating. | 2013-04-04 |
20130084375 | PROCESS FOR DEODORIZING EDIBLE OIL - A process for deodorizing edible oil in a plant includes generating a vacuum in the plant and filling a degassing stage with edible oil which passes through the degassing and separating stages in succession and is treated concurrently with stripping steam; and heating the batch in the separating stages of the stripping column's upper section to 150 to 180° C., middle section to 230 to 260° C., and cooling the lower section to 90 to 120° C.; scrubbing and condensing vapors departing from the separating stages of the upper and lower sections with fatty acid to get mixed fatty acid distillate; indirectly heating a batch in a first separating stage in the stripping column middle section; and condensing that batch from separation stages vapors of the stripping column middle section and fractionating selectively into a first and second fatty acid phase, respectively rich and poor in sterols and tocopherols. | 2013-04-04 |
20130084376 | BREWING APPARATUS FOR EXTRACTING A PORTION CAPSULE - A brewing apparatus for extracting a portion capsule includes a first brewing chamber element and a second brewing chamber element, wherein the first and/or the second brewing chamber element are/is movable in an axial direction between a loading position, in which the first and the second brewing chamber elements are spaced apart from each other, and an extraction position, in which the first and the second brewing chamber elements form a substantially closed brewing chamber and wherein the first brewing chamber element has at least one first perforation means for perforating the portion capsule, said perforation means being arranged along the Earth's gravitational field below a horizontal plane extending substantially at a right angle to the gravitational field and centrally through the brewing chamber. | 2013-04-04 |
20130084377 | DOUGH TRAY AND METHOD OF DISTRIBUTING DOUGH - A dough tray is provided for distributing dough. The dough tray includes a plurality of dough wells, a plurality of grooves defined by the dough wells, and a plurality of denesting features. | 2013-04-04 |
20130084378 | AMINO ACID SEASONING COMPOSITIONS COMPRISING L-GLUTAMIC ACID AND L-LYSINE - The present invention relates to a complex amino acid seasoning composition, comprising L-glutamic acid and L-lysine; wherein the composition is in the amorphous form and exhibits pH 6.5-8.0 in an aqueous solution. In addition, the present invention relates to a preparation method of the complex amino acid seasoning composition. The present invention provides amino acid seasoning compositions with excellent sensory properties in terms of saltiness and umami by use of L-glutamic acid and L-lysine. In contrast to conventional technologies, the present invention enables to block bitterness and offensive odor originated from amino acid ingredients, providing health-friendly seasoning compositions with no sodium ingredient. The seasoning composition of the present invention can be prepared with no formation of L-glutamic acid.L-lysine crystals in a very convenient and cost-effective manner. | 2013-04-04 |
20130084379 | ACTIVE INGREDIENT DELIVERY SYSTEM - A delivery system in the form of a solid dispersion that includes a carrier material of a crystalline matrix material, such as erythritol or mannitol and a solid active ingredient having the structure | 2013-04-04 |
20130084380 | PROCESS OF PREPARING BURDOCK COMPOSITE MICRON ESSENCE - A process of preparing a burdock composite micron essence at least includes the following. Dissolved and heated phospholipid is added to a vegetable oil extract and then stirred. After stirring, the above mixture is pour into a heated glycerol and then further stirred and a burdock extract aqueous solution is added. The aforementioned mixed solution is stirred at high speed, the emulsion-homogenized solution is subject to high-pressure homogenization, and a filtration membrane is used to filter the homogenized solution obtained to get a purple transparent burdock concentrate. The burdock concentrate is used to prepare the formulation of nano-micro emulsion which is easily absorbed by human body and thus grants improved health benefits. | 2013-04-04 |
20130084381 | STERILIZATION OF POLYMERIC MATERIALS - A method of sterilizing a polymeric material that is sensitive to radiation. The method includes the steps of applying at least one radiosensitizer to the polymeric material and irradiating the polymeric material with a suitable radiation at an effective dose and time to sterilize the polymeric material. Also disclosed is a method of enhancing the ability of a medical device to withstand sterilization by radiation and a bioabsorbable polymeric medical device. | 2013-04-04 |
20130084382 | EXTRUDED CABLE STRUCTURES AND SYSTEMS AND METHODS FOR MAKING THE SAME - Cable structures can be formed for cables and other components that include non-cable components such as jacks and headphones. The cable structure includes an outer jacket that is formed from a silicon polymer-based material that is extruded to form a jacket that completely encapsulates a conductive bundle. The cable structures utilizing silicon polymer-based materials can be simple two-ended cables or they can include several legs connected at a point of bifurcation. The extrusion process can be used to manufacture the multiple legs even if they are to be formed of different dimensions. As the silicon polymer-based material is processed by an extruder, one or more system factors of the extruder can be dynamically adjusted to change the diameter of the resulting leg (e.g., to provide a smooth leg having a changing size). | 2013-04-04 |
20130084383 | METHOD AND ARRANGEMENT OF CROSSLINKING OR VULCANISING AN ELONGATE ELEMENT - A method and arrangement of crosslinking or vulcanising an elongate element in which method a conductor element is coated by a layer of crosslinkable synthetic material in an extrusion step and the crosslinking reaction is carried out after the extrusion step. The conductor element is pre-heated in a pre-heating step before the extrusion step by generating inductively eddy currents inside the conductor element which will heat up the conductor element. The pre-heating step is carried out by increasing temperature of the conductor element gradually so that temperature difference between outermost region of the conductor element and the inner layer of the conductor element remains below a pre-determined level at the end of the pre-heating step. | 2013-04-04 |
20130084384 | MANUFACTURING METHOD OF SECONDARY PARTICLES AND MANUFACTURING METHOD OF ELECTRODE OF POWER STORAGE DEVICE - The conductivity of an active material layer provided in an electrode of a secondary battery is sufficiently increased and active material powders in a slurry containing active materials each have a certain size. Secondary particles are manufactured through the following steps: mixing at least active material powders and oxidized conductive material powders to form a slurry; drying the slurry to form a dried substance; grinding the dried substance to form a powder mixture; and reducing the powder mixture. Further, an electrode of a power storage device is manufactured through the following steps: forming a slurry containing at least the secondary particles; applying the slurry to a current collector; and drying the slurry over the current collector. | 2013-04-04 |
20130084385 | METHOD FOR PRODUCING CORE-SHELL MAGNETIC ALLOY NANOPARTICLE - A method for producing core-shell magnetic alloy nanoparticle, comprising: step 1, dissolving nickel compound to produce solution; step 2, adding surfactant into the solution; step 3, dissolving the first reducing agent to produce the first reducing solution; step 4, adding the first reducing solution into the solution obtained from step 2, obtaining nickel nano-collosol by stirring and aging; step 5, adding metallic compound into the nickel nano-collosol; step 6, dissolving the second reducing agent to produce the second reducing solution; step 7, adding the second reducing solution into the mixed solution obtained from step 5; step 8, allow the product to stand, then discarding the supernatant, redispersing in water or absolute ethyl alcohol to obtain the core-shell magnetic alloy nanoparticle using nickel as the core. | 2013-04-04 |
20130084386 | METHOD OF MANUFACTURING A GLASS SUBSTRATE FOR A MAGNETIC DISK AND METHOD OF MANUFACTURING A MAGNETIC DISK - A method of manufacturing a magnetic disk glass substrate has a cleaning step of cleaning the glass substrate. In the cleaning step, the cleaning is performed under an acidic condition using a cleaning liquid containing oxalate ions and bivalent iron ions. In parallel with the cleaning step or before or after the cleaning step, trivalent iron ions generated by oxidation of the bivalent iron ions contained in the cleaning liquid are reduced by ultraviolet irradiation. | 2013-04-04 |
20130084387 | METHOD FOR MAKING A PATTERNED PERPENDICULAR MAGNETIC RECORDING DISK HAVING A FePt or CoPt CHEMICALLY ORDERED RECORDING LAYER - A method for making a bit-patterned-media (BPM) magnetic recording disk includes depositing a FePt (or CoPt) alloy recording layer, and then depositing a sealing layer on the FePt layer before high-temperature annealing. The high-temperature annealing causes the FePt to become substantially chemically-ordered in the L1 | 2013-04-04 |
20130084388 | QUASI MELT BLOW DOWN SYSTEM - A melt blown system for adding a fine fiber layer to a substrates includes a die assembly, a first channel in the die assembly for carrying a first fluid, a first cavity fluidically coupled to the first channel that is configured to collect the first fluid, a first orifice for carrying a second fluid through the die assembly which is fluidically coupled to a second orifice in the die assembly by at least one channel, a plurality of first nozzles in the die assembly that are fluidically coupled to the first orifice, a plurality of second nozzles in the die assembly that are fluidically coupled to the second orifices, and a plurality of third nozzles in the die assembly that are fluidically coupled to the first cavity. | 2013-04-04 |
20130084389 | METHOD AND CERAMIC COMPONENT - A method of fabricating a ceramic component includes using vapor infiltration to deposit a ceramic coating within pores of a porous structure to form a preform body with residual interconnected porosity. Transfer molding is then used to deposit a heated, liquid glass or glass/ceramic material into the residual interconnected porosity. The liquid ceramic or ceramic/glass material is then solidified to form a ceramic component. | 2013-04-04 |
20130084390 | FILM-FORMING APPARATUS AND FILM-FORMING METHOD - A film-forming apparatus and film-forming method comprising a film-forming chamber for being supplied a reaction gas, a substrate placed on a susceptor in the film-forming chamber, a heater for heating the substrate, a transfer chamber adjacent to the film-forming chamber, transferring the substrate to the film-forming chamber, measuring the temperature of the substrate, rotating the substrate via the susceptor, a detecting unit for detecting rotating direction and angle of the rotating unit, generating data of the substrate using temperature data of the substrate measured by the temperature-measuring unit while the substrate is rotating, and positional data of coordinates at which temperature is measured, generated based on the rotating direction and angle, acquiring data of the movement direction and amount of positional error of the substrate based on the data, a control unit for adjusting position of the transfer unit based on the amount of position error of the substrate. | 2013-04-04 |